IP Library Patent Application 14876634
Patent Application
App. No. 14/876,634

Prodrugs of Fluorinated Mevalonates to Inhibit the Mevalonate Pathway of Streptococcus pneumoniae

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/876,634
Abstract

Fluorinated prodrug compounds as can be used for selective streptococcal mevalonate pathway inhibition.

Claims (28)

1 . A compound of a formula

wherein X is selected from NH, O and S; R 1 is selected from mono- and polyfluoro-substituted methyl moieties; and R 2 is selected from alkyl, mono- and polyfluoro-substituted alkyl, alkanoyloxy, cycloalkyl, mono- and polyfluoro-substituted cycloalkyl, aryl, mono- and polyfluoro-substituted aryl, arylalkyl, and mono- and polyfluoro-substituted arylalkyl moieties; and hydrates and solvates thereof.

2 . The compound of claim 1 wherein X is selected from NH and O; and R 1 is selected from fluoromethyl and trifluoromethyl moieties.

3 . The compound of claim 2 wherein R 2 is selected from mono- and polyfluoro-substituted arylalkyl moieties.

4 . The compound of claim 3 wherein R 2 is selected from mono- and difluoro-substituted benzyl moieties.

5 . The compound of claim 1 in at least one of human plasma and contact with an enzyme in a streptococcal mevalonate biosynthetic pathway.

6 . A compound of a formula

wherein X is selected from NH, O and S; R 1 is selected from mono- and polyfluoro-substituted methyl moieties; and R 2 is selected from alkyl, mono- and polyfluoro-substituted alkyl, aryl, mono- and polyfluoro-substituted aryl, arylalkyl, and mono- and polyfluoro-substituted arylalkyl moieties; and hydrates and solvates thereof.

7 . The compound of claim 6 wherein X is selected from NH and O; and R 1 is selected from fluoromethyl and trifluoromethyl moieties.

8 . The compound of claim 7 wherein R 2 is selected from aryl, mono- and polyfluoroaryl, arylalkyl, mono- and polyfluoroarylalkyl moieties.

9 . The compound of claim 8 wherein R 2 is selected from phenyl, mono- and polyfluorophenyl, benzyl, monofluorobenzyl and polyfluorobenzyl moieties.

10 . A compound of a formula

wherein X is selected from NH, O and S; R 1 is selected from mono- and polyfluoro-substituted methyl moieties; and R 2 is selected from alkyl, mono- and polyfluoro-substituted alkyl, aryl, mono- and polyfluoro-substituted aryl, arylalkyl, mono- and polyfluoro-substituted arylalkyl moieties; and R 3 and R 4 are independently selected from H, alkyl, alkoxyalkyl, aryl and arylalkyl moieties; and hydrates and solvates thereof.

11 . The compound of claim 10 wherein X is selected from NH and O; and R 1 is independently selected from fluoromethyl and trifluoromethyl moieties.

12 . The compound of claim 11 where R 2 is selected from arylalkyl, mono- and polyfluoro-substituted arylalkyl moieties.

13 . The compound of claim 10 wherein R 3 and R 4 are independently selected from H and alkyl moieties.

14 . The compound of claim 13 wherein at least one of R 3 and R 4 is methyl.

15 . A compound of a formula

wherein X is selected from NH, O and S; R 1 is selected from mono- and polyfluoro-substituted methyl moieties; R 2 is selected from alkyl, mono- and polyfluoro-substituted alkyl, aryl, mono- and polyfluoro-substituted aryl, arylalkyl, mono- and polyfluoro-substituted arylalkyl moieties; and R 3 and R 4 are independently selected from H, acetyl, propionyl and alkoxyalkyl moieties; and hydrates and solvates thereof.

16 . The compound of claim 15 wherein X is selected from NH and O; and R 1 is selected from fluoromethyl and trifluoromethyl moieties.

17 . The compound of claim 16 wherein R 2 is selected from alkyl, mono- and polyfluoro-substituted alkyl, aryl, mono- and polyfluoro-substituted aryl, arylalkyl, mono- and polyfluoro-substituted arylalkyl moieties.

18 . The compound of claim 15 wherein X is O; R 2 is selected from alkyl, aryl and arylalkyl moieties; and R 3 and R 4 are independently selected from H and acetyl moieties.

19 . The compound of claim 18 wherein at least one of R 3 and R 4 is acetyl.

20 . A compound of a formula

wherein R 1 is selected from mono- and polyfluoro-substituted methyl moieties; and R 2 is selected from acetyl, propionyl and alkoxyalkyl moieties; and hydrates and solvates thereof.

21 . The compound of claim 20 wherein R 1 is selected from fluoromethyl and trifluoromethyl moieties.

22 . The compound of claim 21 wherein R 2 is selected from acetyl and propionyl moieties.

23 . The compound of claim 22 wherein R 2 is acetyl.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 13, 2016
From: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
To: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
Reel/Frame 037475/0524 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 4, 2015
From: LEYH, THOMAS S.
To: ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
Reel/Frame 037215/0694 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 6, 2015
From: SILVERMAN, RICHARD B.; WATANABE, MIZUKI; KANG, SOOSUNG
To: NORTHWESTERN UNIVERSITY
Reel/Frame 036982/0414 →